Home Latest Featured Urgent
Paid Trials
  • Home
  • Browse Clinical Trials
    • Featured Clinical Trials
    • Urgently Recruiting
    • Latest Clinical Trials
  • For Participants
  • For Organizations
  • Clinical Trial Solutions
  • Contact Us
  • About Us
  • Become An Affiliate
  • Legal
    • Terms of Use
    • Privacy Policy
    • Refunds Policy
    • Content Disclaimer
Download on the App Store

Get it on Google Play
Paid Trials
logo
  • Home
  • Browse Clinical Trials
    • Featured Clinical Trials
    • Urgently Recruiting
    • Latest Clinical Trials
    • Clinical Trials by Location
  • For Participants
  • For Organizations
Login / Sign Up
Login to your account
Forgot your password?
or
Facebook
Google
Don't have an account? Register now

If you are an organization, you must create an account to post clinical trials.
Reset Password
Please Enter Username or Email
Back To Login
Create a free account
  • I'm a Participant
  • I'm an Organization
Email *
Password *
Confirm Password *
Email *
Password *
Confirm Password *
Already have an account? Sign in

Paid Clinical Trials for Recurrent Melanoma

  1. Home
  2. Jobs
  3. Recurrent Melanoma
Show Filter
Close

Filter Results:

Search radius: 50 miles
Show More
Show More
Show More
$0 - $11,500
Create alerts based on your search criteria and receive email notifications when new clinical trials become available.
Showing all 4 results
CTG

Phase 1 Dose Escalation and Expansion Study of PRAME T Cell Receptor (TCR) Engineered NK Cells in Participants With Recurrent and/or Refractory Melanoma (PRAMETIME-Mel)

by CTG
in Refractory Melanoma, Phase 1, Recurrent Melanoma
Other
Texas
Deadline:
12/31/2031
CTG

Dabrafenib and Trametinib Followed by Ipilimumab and Nivolumab or Ipilimumab and Nivolumab Followed by Dabrafenib and Trametinib in Treating Patients With Stage III-IV BRAFV600 Melanoma

by CTG
in Recurrent Melanoma, Clinical Stage III Cutaneous Melanoma AJCC v8, Clinical Stage IV Cutaneous Melanoma AJCC v8, Unresectable Melanoma, Metastatic Melanoma
Other
Alabama
Deadline:
09/11/2026
CTG

Talimogene Laherparepvec and Pembrolizumab in Treating Patients With Stage III-IV Melanoma

by CTG
in Recurrent Melanoma, Stage IIIB Cutaneous Melanoma AJCC v7, Stage IIIA Cutaneous Melanoma AJCC v7, Stage III Cutaneous Melanoma AJCC v7, Advanced Melanoma
Other
Alabama
Deadline:
11/04/2026
CTG

Riluzole and Sorafenib Tosylate in Treating Patients With Advanced Solid Tumors or Melanoma

by CTG
in Recurrent Melanoma, Stage IIIA Cutaneous Melanoma AJCC v7, Stage III Cutaneous Melanoma AJCC v7, Refractory Malignant Solid Neoplasm, Advanced Malignant Solid Neoplasm
Other
New Jersey
Deadline:
09/17/2026
logo
Follow us on social media:
Facebook Twitter Linkedin
Participants
  • Find Paid Clinical Trials
  • Featured Clinical Trials
  • Latest Clinical Trials
  • Urgently Recruiting
  • Clinical Trials by Location
Organizations
  • Clinical Trial Recruitment
  • Clinical Trial Solutions
  • AI Solutions
  • Support Portal
  • FAQs
Products
  • Clinical Trial Recruitment
  • Targeted Campaigns
  • White Label Solutions
  • Advanced Voice AI
  • CTMS Software
About Us
  • About Us
  • Contact Us
  • System Status
  • Become an Affiliate
  • Our Blog
Mobile Apps
Download EZ Clinical Trial App on the App Store
Get EZ Clinical Trial App on Google Play

© 2026 Paid Trials | All Right Reserved.

Terms of Use | Privacy Policy | Content Disclaimer

Get new clinical trials sent to you?

We'll send you occasional emails about new clinical trials as soon as they become available for enrollment.

Newsletter

Accelerate enrollment with targeted advertising campaigns

Step 1: Add a recruitment campaign (optional)

Our expert team has 10+ years running successful recruitment campaigns for clinical research sites

Your plan includes posting your clinical trials on our recruitment portal and mobile apps. Boost your trials with targeted advertising campaigns to reach more participants, faster.

What you get with a targeted campaign

We handle everything: audience targeting, creative development, geo targeting to your site locations, and ongoing optimizations. Qualified participant inquiries flow directly into your dashboard. Inquiries typically begin within a few days and continue throughout the campaign.

  • ✓ Reach participants beyond our portal
  • ✓ Geo targeted to your site's catchment area
  • ✓ Continuous optimization by our team
  • ✓ Multi-channel reach (search, social, display, email)

Select your study's therapeutic area and indication below. This helps us calculate accurate campaign budget and delivery timelines based on recruitment complexity.

Maximum participant inquiries available for this indication.

Cost per Inquiry

—

Total Campaign Investment

—

Estimated Campaign Duration

—

Timeline varies based on campaign performance and audience targeting.

Questions about targeted advertising campaigns? Learn more.